Analyst Scoreboard: 6 Ratings For Clene
Portfolio Pulse from Benzinga Insights
Analysts have provided mixed evaluations for Clene Inc. (NASDAQ: CLNN) over the past three months, with all six analysts maintaining a 'Buy' rating. The average 12-month price target is $6.33, with a high of $7.00 and a low of $5.00. However, the average price target has decreased by 9.57%. Clene faces financial challenges, including a revenue decline of -31.78%, a net margin of -15178.08%, and a high debt-to-equity ratio of 7.61.
May 23, 2024 | 2:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Clene Inc. (NASDAQ: CLNN) has received consistent 'Buy' ratings from six analysts, but the average price target has decreased by 9.57% to $6.33. The company faces significant financial challenges, including a revenue decline of -31.78%, a net margin of -15178.08%, and a high debt-to-equity ratio of 7.61.
Despite maintaining 'Buy' ratings, the decrease in the average price target and significant financial challenges suggest a neutral short-term impact on the stock price. Investors may be cautious due to the company's financial performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100